|
|
 |
|
Viewing report
|
|
|
|
Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
Datamonitor, Dec 2009, Pages: 160
The development of therapeutic vaccines has expanded beyond cancer indications and is attracting increasing interest from Pharma and Biotech, driven by potential advantages such as improved specificity, long-lasting immune response and cost-savings compared to conventional pharmacotherapy. First candidates have reached late-stage clinical development.
Scope
- Strategic analysis of therapeutic vaccine pipelines and key clinical candidates across several disease areas outside cancer
- Thorough assessment of opportunities and challenges for therapeutic vaccine development
- Review of potential strategies to increase the efficacy of therapeutic vaccines
- In-depth discussion of key target diseases, unmet needs and rationales for therapeutic vaccine development
Highlights of this title
Efficacy and safety as well as the lack of suitable animal models remain key issues in therapeutic vaccine design and development. A prudent combination of suitable antigens, adjuvants and delivery systems will be crucial to creating efficacious therapeutic vaccines.
Other strategies to increase the efficacy of therapeutic vaccination may include a combination of therapeutic vaccination and pharmacotherapy as well as targeting of early-stage patients, who are more likely to mount a sufficient immune response.
Candidates for the treatment of substance dependence and diabetes have advanced furthest, whereas experts are more sceptical about the prospects of therapeutic vaccination in cardiovascular and autoimmune diseases. Disease-specific risk/benefit profiles will be key to regulatory approval.
Key reasons to purchase this title
- Review therapeutic vaccine progress in four key disease areas outside cancer
- Gain insight into the market environment for therapeutic vaccines through an analysis of pipelines, key candidates and regulatory trends
- Understand challenges, unmet needs and future opportunities by learning about the views of industry and academic key opinion leaders
Customers who bought this item also bought
Nitric Oxide - Therapeutics, Markets and Companies
Special Report: The Autoimmune Biologics Pipeline-A Competitive Review
Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates
Exploring New Opportunities in the Expanding Diabetes Market: Novel Targets and Strategies
DNA Vaccines
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
The Immune/Inflammatory Pipeline: A Strategic Review
Immune Modulation Therapeutics
R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Emerging Microbiology Tests and Companies Developing New Technologies and Products
|
|
|
|
